Member Info for Wigster77

Unless I'm missing something 800 barrels per day is 200000 barrels per year based on 250 days of the year producing. Nearer 300000 if its 7 days a week production.

You never know Thornogson. I do seem to recall a similar SP change (drop in this case) on the Friday prior to the bad Velociraptor news RNS, so hopefully this recent rise does signify an upcoming positive RNS "any day now!!!" (just put that phrase to keep WOS happy). Guess we'll just have to wait for that little red dot...

Anyway, good luck to all involved in this stock - we deserve it for the patience shown.

"MB should've attended this conference"

Do we know he definitely hasn't attended? (sorry if I've missed this)

"I'm all for a bit of a re-rate at the time"

What's your estimate for this? 6-8p maybe, or a touch more?

ATB

My personal expectation for the next substantial RNS is January-February. Based on nothing more than managing my expectations so I'm not disappointed when I log in each morning and there's a lack of "red dot".

Hope it will be sooner...it could be a lot sooner. Even "any day" as WOS likes to tell us :-) Hopefully it will come at some point though and will be as positive and fruitful as we all hope. In the meantime I've got plenty of other frustrating stocks to help divert my attention from this one!

ATB & GLA.

Agree Doc. If the Mongolians can't unblock this regulatory/red tape/"appease the locals" pipe in order to release hundreds of millions of barrels of oil, at a time when the country is facing crippling fuel shortages, then they really are beyond incompetent..

At the risk of sounding like WOS (!) - hopefully not too much longer to wait now.

ATB & GLA

Here's a quick example I found whilst quickly googling at work, Surfer - a recent agreement between Quell therapeutics and Astra-Zeneca. Nice figures: $85M upfront and over $2 BILLION in further milestone payments PLUS potential royalties and further payments/royalties etc for U.S. sales.

Something similar would be OK for Synairgen I'd guess...

----

Financial considerations

Quell will receive $85 million upfront from AstraZeneca, which comprises a predominant cash payment and an equity investment. Quell is also eligible to receive over $2 billion for further development and commercialisation milestones, if successful, plus tiered royalties.

In addition, Quell retains an option, which can be exercised either after approval of an Investigational New Drug (IND) application or at the end of the Phase I/II clinical study, to co-develop Treg cell therapies from the T1D programme with AstraZeneca in the United States in exchange for additional milestone payments and increased royalties on US net sales.

----

ATB & GLA

Agree TP, my expectations for the next news is hearing more about these trials (be-it protocols/commencement dates etc) some time around February/March.

ATB & GLA

So from that, we can infer that when RM calls for a meeting with these 2 special shareholders to tell them nothing is happening, actually the reverse is true? Please do let us know when the next meeting is called.

GLA & ATB

Yes, the message from RM at the AGM was that all potential big pharma partners they've spoken to said they needed to see more positive data to prove the potential of the drug. Hopefully the P2 studies will deliver this. If not, it's curtains.

ATB & GLA.

I can't wait for MrCosts' take on this...he's going to have a field day.

Thanks Jint, appreciate the additional information.

"SNG are working with an unknown partner on the test"

My memory is hazy, but I seem to recall Casanova Labs being mentioned at the AGM so maybe it's them.

I'm pretty sure you'll have already seen it, but there was a presentation about this given at the AGM. I think the slides are on the Synairgen website somewhere.

"We might just get an RNS we have been waiting for by Wednesday when MB has his speech"

Sounds exciting!! What percentage chance would you put on this happening?...95%?...99%?

I can't see anything too significant resulting from this meeting personally. It may be a nice opportunity for a bit of networking and PR, but I just can't see it making much difference to our immediate situation. Hopefully I'm wrong and WOS's....sorrry Hamm's numerous posts today of "top up now!!" and "any time now!!" sentiments will prove correct.

GLA & ATB

"This forum seems a vehicle mainly to whine, and troll each other, with the odd snippet of useful information posted by a few here and there"

Welcome to the world of LSE forums, looks like you'll enjoy it. And you ain't seen nothing yet...there's a poster called WiseOwlSpeak who mercifully has been on holiday recently. Wait until he returns, for the full undiluted experience on here...

Thanks Nessab.

"Investors should look forward to the above mentioned observational study and two trials. The outputs of these will form the basis for an expected Phase 3 study in severe anti-viral infections, expected to begin in H1 2024 and significantly advance SNG001's clinical development."

I presume they mean H1 2025 for P3 (which I think would be a bit optimistic, but hey, what do I know!)

ATB & GLA.

Que?

I'd love it, just love it, if there's a procession of great RNSs at the very moment our resident "any day now!!" BOOOOOOOOMing expert WOS is off for 2 weeks buying new pants and (hopefully) getting his Irritable Owl Syndrome sorted. Be happy!!!!!!!! X30000 BAGGER INCOMING....ANY DAY NOW!!!!! STRONG BUYING DETECTED!!!!!! BREAKOUT IMMANANT!!!!!!